Pehrson R[au] - Search Results

Year	Number of Results
1999	1
2002	4
2003	4
2006	1
2007	2
2008	1
2010	1
2011	1
2012	2
2013	3
2014	2
2015	1
2016	1
2017	1
2018	1
2020	1
2021	1
2023	0

1

CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.

Andersson KE, Pehrson R. Andersson KE, et al. Among authors: pehrson r. Drugs. 2003;63(23):2595-611. doi: 10.2165/00003495-200363230-00003. Drugs. 2003. PMID: 14636079 Review.

2

AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2.

Narjes F, Llinas A, von Berg S, Jirholt J, Lever S, Pehrson R, Collins M, Malmberg A, Svanberg P, Xue Y, Olsson RI, Malmberg J, Hughes G, Hossain N, Grindebacke H, Leffler A, Krutrök N, Bäck E, Ramnegård M, Lepistö M, Thunberg L, Aagaard A, McPheat J, Hansson EL, Chen R, Xiong Y, Hansson TG. Narjes F, et al. Among authors: pehrson r. J Med Chem. 2021 Sep 23;64(18):13807-13829. doi: 10.1021/acs.jmedchem.1c01197. Epub 2021 Aug 31. J Med Chem. 2021. PMID: 34464130

3

Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism.

Danielsson C, Brask J, Sköld AC, Genead R, Andersson A, Andersson U, Stockling K, Pehrson R, Grinnemo KH, Salari S, Hellmold H, Danielsson B, Sylvén C, Elinder F. Danielsson C, et al. Among authors: pehrson r. Cardiovasc Res. 2013 Jan 1;97(1):23-32. doi: 10.1093/cvr/cvs296. Epub 2012 Sep 20. Cardiovasc Res. 2013. PMID: 22997158

4

Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284.

Asimus S, Palmér R, Albayaty M, Forsman H, Lundin C, Olsson M, Pehrson R, Mo J, Russell M, Carlert S, Close D, Keeling D. Asimus S, et al. Among authors: pehrson r. Br J Clin Pharmacol. 2020 Jul;86(7):1398-1405. doi: 10.1111/bcp.14253. Epub 2020 Mar 3. Br J Clin Pharmacol. 2020. PMID: 32067249 Free PMC article. Clinical Trial.

5

AZD7624, an Inhaled p38 Inhibitor, Demonstrates Local Lung Inhibition of LPS-Induced TNFα with Minimal Systemic Exposure.

Pehrson R, Hegelund-Myrbäck T, Cunoosamy D, Asimus S, Jansson P, Patel N, Borde A, Lundin S. Pehrson R, et al. J Pharmacol Exp Ther. 2018 Jun;365(3):567-572. doi: 10.1124/jpet.117.246132. Epub 2018 Mar 16. J Pharmacol Exp Ther. 2018. PMID: 29549158

6

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.

Orlova A, Tolmachev V, Pehrson R, Lindborg M, Tran T, Sandström M, Nilsson FY, Wennborg A, Abrahmsén L, Feldwisch J. Orlova A, et al. Among authors: pehrson r. Cancer Res. 2007 Mar 1;67(5):2178-86. doi: 10.1158/0008-5472.CAN-06-2887. Cancer Res. 2007. PMID: 17332348

7

Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples.

Gabrielsson J, Hjorth S, Vogg B, Harlfinger S, Gutierrez PM, Peletier L, Pehrson R, Davidsson P. Gabrielsson J, et al. Among authors: pehrson r. Eur J Pharm Sci. 2015 Jan 25;67:144-159. doi: 10.1016/j.ejps.2014.11.006. Epub 2014 Nov 28. Eur J Pharm Sci. 2015. PMID: 25435491

8

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.

Tolmachev V, Orlova A, Pehrson R, Galli J, Baastrup B, Andersson K, Sandström M, Rosik D, Carlsson J, Lundqvist H, Wennborg A, Nilsson FY. Tolmachev V, et al. Among authors: pehrson r. Cancer Res. 2007 Mar 15;67(6):2773-82. doi: 10.1158/0008-5472.CAN-06-1630. Cancer Res. 2007. PMID: 17363599

9

Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis.

Golman K, Zandt RI, Lerche M, Pehrson R, Ardenkjaer-Larsen JH. Golman K, et al. Among authors: pehrson r. Cancer Res. 2006 Nov 15;66(22):10855-60. doi: 10.1158/0008-5472.CAN-06-2564. Cancer Res. 2006. PMID: 17108122 Free article.

10

Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.

Sällström J, Al-Saffar A, Pehrson R. Sällström J, et al. Among authors: pehrson r. J Pharmacol Toxicol Methods. 2014 Jan-Feb;69(1):24-9. doi: 10.1016/j.vascn.2013.10.001. Epub 2013 Oct 16. J Pharmacol Toxicol Methods. 2014. PMID: 24140388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results